Detalhe da pesquisa
1.
Long-term antigen-specific immune response by an oncolytic adenovirus encoding SP-SA-E7-4-1BBL in HPV-16 cancer model.
Mol Biol Rep
; 51(1): 408, 2024 Mar 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38460043
2.
Beyond the anti-PD-1/PD-L1 era: promising role of the BTLA/HVEM axis as a future target for cancer immunotherapy.
Mol Cancer
; 22(1): 142, 2023 08 30.
Artigo
Inglês
| MEDLINE | ID: mdl-37649037
3.
Immunoglobulin-like transcript 2 blockade restores antitumor immune responses in glioblastoma.
Cancer Sci
; 114(1): 48-62, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36082628
4.
BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia.
Cancer Immunol Immunother
; 72(7): 2529-2539, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37041226
5.
4-1BBL as a Mediator of Cross-Talk between Innate, Adaptive, and Regulatory Immunity against Cancer.
Int J Mol Sci
; 22(12)2021 Jun 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34207500
6.
Correction: Long-term antigen-specific immune response by an oncolytic adenovirus encoding SP-SA-E7-4-1BBL in HPV-16 cancer model.
Mol Biol Rep
; 51(1): 565, 2024 Apr 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38649646
7.
Chemo-Immunotherapy: A New Trend in Cancer Treatment.
Cancers (Basel)
; 15(11)2023 May 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37296876
8.
The Emerging Role of NK Cells in Immune Checkpoint Blockade.
Cancers (Basel)
; 14(23)2022 Dec 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36497486
9.
An Oncolytic Adenovirus Encoding SA-4-1BBL Adjuvant Fused to HPV-16 E7 Antigen Produces a Specific Antitumor Effect in a Cancer Mouse Model.
Vaccines (Basel)
; 9(2)2021 Feb 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33673295